ID: ALA538990

Max Phase: Preclinical

Molecular Formula: C17H19ClF2N2

Molecular Weight: 288.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.Fc1ccc(N(c2ccc(F)cc2)C2CCNCC2)cc1

Standard InChI:  InChI=1S/C17H18F2N2.ClH/c18-13-1-5-15(6-2-13)21(17-9-11-20-12-10-17)16-7-3-14(19)4-8-16;/h1-8,17,20H,9-12H2;1H

Standard InChI Key:  GVFPNVADSOWHCE-UHFFFAOYSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 288.34Molecular Weight (Monoisotopic): 288.1438AlogP: 3.85#Rotatable Bonds: 3
Polar Surface Area: 15.27Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.78CX LogP: 3.57CX LogD: 1.24
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.92Np Likeness Score: -0.59

References

1. Sarges R, Howard HR, Donahue KM, Welch WM, Dominy BW, Weissman A, Koe BK, Bordner J..  (1986)  Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.,  29  (1): [PMID:3941416] [10.1021/jm00151a002]

Source